Article
Clinical utility of molecular subtyping of pancreatic cancer
2019-01-01
Abstract excerpt
Background: Pancreatic Cancer remains a dismal disease with the worst survival outcomes of any solid organ malignancy. The most common form is Pancreatic Ductal Adenocarcinoma (PDAC) which has a 5-year survival of only 5% and a median survival in the region of 6 months after diagnosis. The majority of patients present with metastatic or locally advanced disease that is unsuitable for surgical resection. The only p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d7ed4ba2-5372-5b96-a560-78a46365554f
- DOI
- 10.5525/gla.thesis.74314